Diazepam Pharmakern (Diazepam)

Diazepam Pharmakern is indicated for several therapeutic purposes in clinical practice.

• Management of generalized anxiety disorder and related anxiety states.
• Adjunctive therapy for various seizure disorders, including status epilepticus.
• Relief of skeletal muscle spasm associated with acute musculoskeletal conditions.
• Treatment of symptoms associated with acute alcohol withdrawal.
• Pre‑operative sedation and anxiolysis before surgical procedures.

The safety profile of diazepam includes a range of effects that vary in frequency and severity.

Common

• Drowsiness or sedation.
• Fatigue.
• Muscle weakness.
• Impaired coordination.
• Memory disturbances such as difficulty concentrating.

Serious

• Respiratory depression, especially when combined with other depressants.
• Severe hypotension.
• Paradoxical reactions including agitation, aggression, or hallucinations.
• Dependence or withdrawal symptoms with prolonged use.
• Allergic reactions such as rash, itching, or swelling.

When prescribing or taking Diazepam Pharmakern, clinicians should consider several precautionary measures to minimize risk.

• Assess for a history of substance abuse or dependence before initiating therapy.
• Use the lowest effective dose for the shortest duration possible.
• Caution in patients with respiratory disorders, such as COPD or sleep apnea.
• Avoid abrupt discontinuation to prevent withdrawal phenomena.
• Evaluate liver and kidney function, as impairment may affect drug clearance.
• Discuss potential sedation with activities requiring alertness, such as driving.

Diazepam interacts with a variety of medicines; some combinations should be avoided, while others require careful monitoring.

Avoid

• Concomitant use with other central nervous system depressants (e.g., opioids, barbiturates, alcohol).
• Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, or clarithromycin.
• Drugs that significantly lower seizure threshold (e.g., bupropion).

Use with caution

• Antidepressants, especially SSRIs and SNRIs, due to additive CNS effects.
• Antihistamines and muscle relaxants that may increase sedation.
• Anticonvulsants like phenytoin, which can alter diazepam plasma levels.